These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 33098751

  • 21. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H, Eagle RC, Shields CL, Shields JA.
    Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
    [Abstract] [Full Text] [Related]

  • 22. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma].
    Balwierz W, Kobylarz J, Starzycka M, Dluzniewska A.
    Med Wieku Rozwoj; 2001 Aug; 5(3 Suppl 1):15-23. PubMed ID: 12004148
    [Abstract] [Full Text] [Related]

  • 23. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
    Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP.
    Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
    [Abstract] [Full Text] [Related]

  • 24. First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma.
    Beck MN, Balmer A, Dessing C, Pica A, Munier F.
    J Clin Oncol; 2000 Aug; 18(15):2881-7. PubMed ID: 10920136
    [Abstract] [Full Text] [Related]

  • 25. The success of primary chemotherapy for group D heritable retinoblastoma.
    Cohen VM, Kingston J, Hungerford JL.
    Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556
    [Abstract] [Full Text] [Related]

  • 26. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
    Shields CL, Shelil A, Cater J, Meadows AT, Shields JA.
    Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
    [Abstract] [Full Text] [Related]

  • 27. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA.
    Trans Am Ophthalmol Soc; 2004 Nov; 102():35-44; discussion 44-5. PubMed ID: 15747743
    [Abstract] [Full Text] [Related]

  • 28. Practical approach to management of retinoblastoma.
    Shields CL, Mashayekhi A, Demirci H, Meadows AT, Shields JA.
    Arch Ophthalmol; 2004 May; 122(5):729-35. PubMed ID: 15136321
    [Abstract] [Full Text] [Related]

  • 29. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma.
    Kingston JE, Hungerford JL, Madreperla SA, Plowman PN.
    Arch Ophthalmol; 1996 Nov; 114(11):1339-43. PubMed ID: 8906024
    [Abstract] [Full Text] [Related]

  • 30. Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy.
    Greenwald MJ, Strauss LC.
    Ophthalmology; 1996 Dec; 103(12):1989-97. PubMed ID: 9003332
    [Abstract] [Full Text] [Related]

  • 31. Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapy.
    Lumbroso-Le Rouic L, Aerts I, Hajage D, Lévy-Gabriel C, Savignoni A, Algret N, Cassoux N, Bertozzi AI, Esteve M, Doz F, Desjardins L.
    Eye (Lond); 2016 Jan; 30(1):46-52. PubMed ID: 26427984
    [Abstract] [Full Text] [Related]

  • 32. Visual outcome in macular retinoblastoma treated with primary chemotherapy.
    Balasubramanya R, Pushker N, Bajaj MS, Rani A, Ghose S, Arya LS.
    Ophthalmologica; 2003 Jan; 217(6):417-21. PubMed ID: 14573975
    [Abstract] [Full Text] [Related]

  • 33. A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
    Bartuma K, Pal N, Kosek S, Holm S, All-Ericsson C.
    Acta Ophthalmol; 2014 Aug; 92(5):404-11. PubMed ID: 24119165
    [Abstract] [Full Text] [Related]

  • 34. Predictors of long-term visual outcome after chemoreduction for management of intraocular retinoblastoma.
    Narang S, Mashayekhi A, Rudich D, Shields CL.
    Clin Exp Ophthalmol; 2012 Aug; 40(7):736-42. PubMed ID: 22300311
    [Abstract] [Full Text] [Related]

  • 35. Visual outcomes in children with bilateral retinoblastoma.
    Hall LS, Ceisler E, Abramson DH.
    J AAPOS; 1999 Jun; 3(3):138-42. PubMed ID: 10428586
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis.
    Fabian ID, Stacey AW, Johnson KP, Onadim Z, Chowdhury T, Duncan C, Reddy MA, Sagoo MS.
    Br J Ophthalmol; 2017 Jan; 101(1):82-88. PubMed ID: 27965263
    [Abstract] [Full Text] [Related]

  • 38. Clinical result of prolonged primary chemotherapy in retinoblastoma patients.
    Kim JH, Yu YS, Khwarg SI, Choi HS, Shin HY, Ahn HS.
    Korean J Ophthalmol; 2003 Jun; 17(1):35-43. PubMed ID: 12882506
    [Abstract] [Full Text] [Related]

  • 39. Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation.
    Chan MP, Hungerford JL, Kingston JE, Plowman PN.
    Br J Ophthalmol; 2009 Jul; 93(7):891-4. PubMed ID: 19329423
    [Abstract] [Full Text] [Related]

  • 40. Long-term visual outcomes in intraocular retinoblastoma with eye preservation.
    Batra A, Pushker N, Venkatesh P, Arora T, Tewari R, Bakhshi S.
    Clin Transl Oncol; 2016 Oct; 18(10):1034-8. PubMed ID: 26781471
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.